BrainCool - directed share issue - up to SEK 50m

Arctic Securities acted as sole manager in relation to the directed share issue (units) of up to SEK 50m for the listed medtech company BrainCool AB (publ).

BrainCool AB (publ) develops and sells medical targeted temperature management cooling systems for indications with high unmet medical needs within the healthcare sector. The company focuses on two business segments, Brain Cooling and Pain Management.

We thank BrainCool for the vote of confidence and congratulate on the successful transaction!

Latest news

  1. Arctic Securities -

    Cavendish Hydrogen ASA - Prospectus

    Cavendish Hydrogen has applied for admission to trading of its shares on the main board of the Oslo Stock Exchange. Arctic Securities AS is acting as joint lead manager. Please find the prospectus in connection with the Listing.